Abstract
Urinary activity of the enzyme, N-acetyl-beta-D-glucosaminidase (N.A.G.) was examined as a screening test for renal disease in patients with hypertension. Renal disease was present in 64% of patients with increased N.A.G., compared with only 14% of patients with normal N.A.G. The measurement of N.A.G. is cheap and convenient and this simple test warrants further assessment in hypertension as a guide to the need for further investigation.
MeSH terms
-
Acetylglucosamine
-
Acetylglucosaminidase / urine
-
Analgesics / adverse effects
-
Chronic Disease
-
Diagnostic Errors
-
Glomerulonephritis / diagnosis
-
Humans
-
Hypertension, Renal / diagnosis
-
Hypertension, Renal / enzymology*
-
Kidney Calculi / diagnosis
-
Kidney Diseases / chemically induced
-
Kidney Diseases / diagnosis*
-
Kidney Diseases / enzymology
-
Kidney Diseases, Cystic / diagnosis
-
Nephrotic Syndrome / diagnosis
Substances
-
Analgesics
-
Acetylglucosaminidase
-
Acetylglucosamine